维普中文期刊产品整合服务
13篇 您的检索式:作者名="LUZ Z"
    题名 作者 年代 出处 被引量
1Mono-dispersed bioactive glass nanospheres:preparation and effects on biomechanics of mammalian cells显示文摘Hong Z Luz GM Hampel PJ 2010J Biomed Mater Res A2010,95,3:1
2Malignant peritoneal mesothelioma-diagnostic and therqpeutic difficulties显示文摘Cunha P Luz Z Seves I 2002Acta Med Port2002,15,5:1
3显示文摘Zhang J Luz Z Goldfarb D 1997J Phys Chem B1997,101,36:1
4EPR Studies of the Formation Mechanism of the Mesoporous Materials MCM-41 andMCM-50 显示文摘Zhang J Y Luz Z Goldfarb D 1997J PhysChemB1997,,101:1
5Malignant peritoneal mesothelioma diagnostic and therapeutic difficulties显示文摘Cunha P Luz Z Seves I 2002Acta Med Port2002,15,:1
6Slow exchange involving equivalent sites in solids by one-dimensional MAS NMR techniques显示文摘Luz Z Tekely P Reichert D 2002Prog Nucl Magn Reson Spectrosc2002,41,12:1
7Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin,increased transcriptional activity of beta-catenin,and enhanced tumor cell invasion显示文摘Luz Ghosh S Wang Z 2003Cancer Cell2003,4,6:1
8Nuclear Magnetic Resonance study of protolysis of trimethylammonium Ion in aqueous solution-order of reaction with respect to solvent显示文摘Luz Z Meiboom S 1963J Chem Phys1963,39,2:1
9An improved HAdV-Ⅱ E1B55K-expressing 293 cell line for packaging fastidious adenovirus显示文摘Zou X H Xiao X Chen D L Li Z L Song J D Wang M QuJ G LuZ Z Hung T 2011J Virol Methods2011,175,2:1
10EPR studies of the for-mation mechanism of the mesoporous materials MCM-41 and MCM-50显示文摘Zhang J Luz Z Goldfarb D 1997Phys Chem B1997,101,:1
11EPR studies of the formation mechanism of the mesoporous material MCM-41and MCM-50显示文摘ZHANG J LUZ Z GOLDFARB D 1997J Phy Chem B1997,101,:1
12The formation of the mesoporous material MCM-41 as studied by EPR line shape analysis of spin probes 显示文摘ZHANG J LUZ Z ZIMMERMANN H 2000J Phys Chem B2000,104,:1
13Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR显示文摘AIM To assess KRAS G12 D mutation detection by droplet digital PCR(dd PCR) in stool-derived DNA from colorectal cancer(CRC) patients.METHODS In this study, tumor tissue and stool samples were collected from 70 patients with stage Ⅰ-Ⅳ CRC diagnosed by preoperative biopsy. KRAS mutational status was determined by pyrosequencing analysis of DNA obtained from formalin-fixed paraffinembedded(FFPE) tumor tissues. The KRAS G12 D mutation was then analyzed by dd PCR in FFPE tumors and stool-derived DNA from patients with this point mutation. Wild-type(WT) tumors, as determined by pyrosequencing, were included as controls; analysis of FFPE tissue and stool-derived DNA by dd PCR was performed for these patients as well.RESULTS Among the total 70 patients included, KRAS mutations were detected by pyrosequencing in 32(45.71%), whereas 38(54.29%) had WT tumors. The frequency of KRAS mutations was higher in left-sided tumors(11 located in the right colon, 15 in the left, and 6 in the rectum). The predominant point mutation was KRAS G12 D(14.29%, n = 10), which was more frequent in early-stage tumors(I-IIA, n = 7). In agreement with pyrosequencing results, the KRAS G12 D mutation was detected by dd PCR in FFPE tumor-derived DNA, and only a residual number of mutated copies was found in WT controls. The KRAS G12 D mutation was also detected in stool-derived DNA in 80% of all fecal samples from CRC patients with this point mutation. CONCLUSION dd PCR is a reliable and sensitive method to analyze KRAS G12 D mutation in stool-derived DNA from CRC patients, especially at early stages. This non-invasive approach is potentially applicable to other relevant biomarkers for CRC management.Susana Olmedillas-López Dennis César Lévano-Linares Carmen Laura Aúz Alexandre Luz Vega-Clemente Edurne León Sánchez Alejandro Villagrasa Jaime Ruíz-Tovar Mariano García-Arranz Damián García-Olmo 2017World Journal of Gastroenterology2017,23,39:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费